ABERDEEN STD GOLD ETF TR's ticker is SGOL and the CUSIP is 00326A104. A total of 236 filers reported holding ABERDEEN STD GOLD ETF TR in Q4 2021. The put-call ratio across all filers is 0.25 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $185,391 | -3.7% | 10,480 | 0.0% | 0.02% | +4.2% |
| Q2 2023 | $192,518 | -2.6% | 10,480 | 0.0% | 0.02% | -7.7% |
| Q1 2023 | $197,758 | +8.0% | 10,480 | 0.0% | 0.03% | 0.0% |
| Q4 2022 | $183,086 | +9.6% | 10,480 | 0.0% | 0.03% | -13.3% |
| Q3 2022 | $167,000 | -8.2% | 10,480 | 0.0% | 0.03% | -9.1% |
| Q2 2022 | $182,000 | -6.7% | 10,480 | 0.0% | 0.03% | +6.5% |
| Q1 2022 | $195,000 | +6.0% | 10,480 | 0.0% | 0.03% | -13.9% |
| Q4 2021 | $184,000 | +4.0% | 10,480 | 0.0% | 0.04% | -10.0% |
| Q3 2021 | $177,000 | -0.6% | 10,480 | 0.0% | 0.04% | -18.4% |
| Q2 2021 | $178,000 | +3.5% | 10,480 | 0.0% | 0.05% | -12.5% |
| Q1 2021 | $172,000 | -10.4% | 10,480 | 0.0% | 0.06% | -11.1% |
| Q4 2020 | $192,000 | +1.1% | 10,480 | 0.0% | 0.06% | -18.2% |
| Q3 2020 | $190,000 | +5.6% | 10,480 | 0.0% | 0.08% | -4.9% |
| Q2 2020 | $180,000 | +13.2% | 10,480 | 0.0% | 0.08% | -22.1% |
| Q1 2020 | $159,000 | +3.9% | 10,480 | 0.0% | 0.10% | +20.9% |
| Q4 2019 | $153,000 | – | 10,480 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Hudock, Inc. | 1,147,876 | $18,825,000 | 5.89% |
| UBP Investment Advisors SA | 716,194 | $11,750,000 | 4.80% |
| swisspartners Ltd. | 305,000 | $5,011,000 | 4.07% |
| Darwin Wealth Management, LLC | 1,380,786 | $22,644,000 | 3.95% |
| Cypress Capital, LLC | 527,505 | $8,651,000 | 3.53% |
| Newman Dignan & Sheerar, Inc. | 430,281 | $7,057,000 | 2.56% |
| SimpliFi, Inc. | 318,301 | $5,220,000 | 2.44% |
| Allen Capital Group, LLC | 577,017 | $9,463,000 | 2.08% |
| Almanack Investment Partners, LLC. | 1,191,188 | $19,536,000 | 1.99% |
| American Money Management, LLC | 314,165 | $5,152,000 | 1.92% |